Leukotriene synthesis inhibitor decreases vasopressin release in the early phase of sepsis (2011)
Source: Journal of Neuroimmunology. Unidades: FCFRP, FORP
Subjects: LEUCOTRIENOS, VASOPRESSINAS, SEPSE
ABNT
MARTINS, Thalita Freitas et al. Leukotriene synthesis inhibitor decreases vasopressin release in the early phase of sepsis. Journal of Neuroimmunology, v. 238, n. 1-2, p. 52-57, 2011Tradução . . Disponível em: https://doi.org/10.1016/j.jneuroim.2011.08.001. Acesso em: 01 nov. 2024.APA
Martins, T. F., Sorgi, C. A., Faccioli, L. H., & Rocha, M. J. A. da. (2011). Leukotriene synthesis inhibitor decreases vasopressin release in the early phase of sepsis. Journal of Neuroimmunology, 238( 1-2), 52-57. doi:10.1016/j.jneuroim.2011.08.001NLM
Martins TF, Sorgi CA, Faccioli LH, Rocha MJA da. Leukotriene synthesis inhibitor decreases vasopressin release in the early phase of sepsis [Internet]. Journal of Neuroimmunology. 2011 ; 238( 1-2): 52-57.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.jneuroim.2011.08.001Vancouver
Martins TF, Sorgi CA, Faccioli LH, Rocha MJA da. Leukotriene synthesis inhibitor decreases vasopressin release in the early phase of sepsis [Internet]. Journal of Neuroimmunology. 2011 ; 238( 1-2): 52-57.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1016/j.jneuroim.2011.08.001